Pharmaceutical Grade Apremilast API CAS 608141-41-9

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Pharmaceutical Grade Apremilast API CAS 608141-41-9
CAS No.:608141-41-9
Standard:ChP, USP, BP, EP, JP, In-house Standards, IP, Ph. Int
Price(USD):$1000/kg-$2000/kg
Company:Shandong Loncom Pharmaceutical Co.,Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 100kg

    Contract Manufacturing: CRO,CMO

    Packaging Information: 5kg/drum

  • Delivery Lead Time: 15days

    Sample Provided: yes

    Payment Terms: T/T

    Mechanism of Action

    Apremilast is an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP). PDE4 inhibition results in increased intracellular cAMP levels. The specific mechanism(s) by which apremilast exerts its therapeutic action in psoriatic arthritis patients and psoriasis patients is not well defined.

    Indication

    OTEZLA, an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of:

    • Adult patients with active psoriatic arthritis
    • Patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Send your message to this supplier
  • From:
  • To:
    Shandong Loncom Pharmaceutical Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service